InVivo Therapeutics Holdings Stock
A very strong showing by InVivo Therapeutics Holdings today, with an increase of €0.020 (6.410%) compared to yesterday's price.
The sentiment is rather negative at the moment with 17 Sell predictions and 1 Buy predictions.
On the other hand, the target price of 1 € is above the current price of 0.33 € for InVivo Therapeutics Holdings, so the potential is actually 201.2%.
So far the community has only identified positive things for InVivo Therapeutics Holdings stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of InVivo Therapeutics Holdings in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
M***** P*******
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of InVivo Therapeutics Holdings vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| InVivo Therapeutics Holdings | 6.410% | 3.106% | 4.403% | -71.721% | -51.744% | -99.930% | -99.951% |
| Star Equity Holdings Inc. | 1.240% | 1.242% | 0.617% | -10.440% | -13.298% | -61.916% | -85.801% |
| Atossa Genetics Inc | -5.070% | -6.528% | -4.403% | 66.687% | 43.039% | -49.015% | -64.049% |
| Medmira Inc. | -3.700% | -3.704% | 13.043% | -6.306% | -20.000% | - | - |
Comments
InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for NVIV provided by MarketBeat
InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for NVIV provided by MarketBeat
InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for NVIV provided by MarketBeat